Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Open in API
Filings indexed 881 across all filing types
Latest filing 2017-03-02 Director's Dealing
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 2 pages 246.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including the number of shares held before and after the change, nature of the interest, and dates. This is a report of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document length is 3636 characters, which is consistent with a detailed notice rather than a brief announcement. There is no indication that this is an annual report, audit report, or any other type of filing. Therefore, the correct classification is Director's Dealing (DIRS).
2017-03-02 English
Receipt of R&D Tax Incentive 1 page 103.8KB
Regulatory Filings Classification · 95% confidence The document is a short announcement from Phosphagenics Limited regarding the receipt of an R&D Tax Incentive refund for the 2015-16 tax year. It does not contain any financial statements, detailed financial data, or comprehensive report content. The length is only 1671 characters, which is quite brief and typical of a regulatory or market announcement. There is no indication that this is an annual report, earnings release, or any detailed financial or management report. It is also not a certification or officer attestation. The content is an update on a specific financial event (receipt of a tax refund), which fits best under a general regulatory announcement category. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2017-02-28 English
Phosphagenics - March 2017 Newsletter 5 pages 943.2KB
Annual Report Classification · 95% confidence The document is a detailed company newsletter providing a comprehensive update on the company's progress, financial performance for the full year 2016, strategic developments, R&D activities, partnerships, and legal matters. It references the full year 2016 financial accounts released to the ASX, discusses cash position, spend management, and an 'emphasis of matter' statement from Directors and Auditors. The document contains substantive financial data and analysis, including year-on-year comparisons of net loss, expenses, and cash outflows. It is not merely an announcement of a report but includes detailed commentary and financial results. The length (15,000 characters) and content indicate this is a full financial report covering the company's yearly activity and performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2016
2017-02-28 English
CEO Quarterly Update Teleconference 2 pages 114.9KB
Call Transcript Classification · 70% confidence The document is titled 'CEO Quarterly Update' and invites interested parties to participate in a teleconference with details for joining and Q&A instructions. It includes no financial statements or substantive financial data but rather serves as an announcement for a conference call event. The document length is 3303 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication of actual financial results or detailed analysis within the text. Therefore, this document is best classified as a Call Transcript (CT) announcement or invitation, but since it only contains the invitation and not the transcript itself, it aligns more closely with a Call Transcript category as it relates to a conference call event. Given the content, the best fit is Call Transcript (CT) with moderate confidence as it is an announcement for a call rather than the transcript itself, but no other category fits better.
2017-02-28 English
Appendix 4E and Annual Financial Report 69 pages 1.1MB
Annual Report Classification · 100% confidence The document is titled 'Phosphagenics Limited Appendix 4E Preliminary Final Report' and covers the financial year ended 31 December 2016. It includes detailed financial results, directors' report, auditor's report, consolidated financial statements, and notes. The presence of comprehensive financial statements, directors' report, and auditor's report indicates this is a full annual financial report. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or summary. The document also references the Annual Financial Report attached, and the content matches what would be expected in an Annual Report (10-K equivalent). Therefore, the correct classification is Annual Report (10-K). FY 2016
2017-02-27 English
Phosphagenics Full Year Financial Results 3 pages 126.0KB
Annual Report Classification · 95% confidence The document is titled 'Phosphagenics Full Year Financial Results' and reports financial results for the year ended 31 December 2016. It includes detailed financial data such as net loss after tax, cash position, revenue, expenses, impairment losses, and operational highlights. The document also discusses business strategy, partnerships, legal activities, and outlook statements. The length of the document (8345 characters) and the presence of substantive financial data and analysis indicate it is a full annual financial report rather than a brief announcement or summary. There is no indication that this is merely an announcement of a report or a certification. Therefore, the document fits the definition of an Annual Report (10-K equivalent). FY 2016
2017-02-27 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.